Many Glaucoma Patients Don’t Take Medication Properly
A study that appears in the May edition of Ophthalmology, the clinical journal of the American Academy of Ophthalmology, shows that as many as 47 percent of patients receiving glaucoma therapy do not comply with their doctor’s prescribed medicine regimen. This is in startling contrast to the 90 percent of doctors who believe that their patients are following the prescribed treatment.
“Non-adherence to the glaucoma therapy is probably what causes patients to go blind,” said Alan L. Robin, M.D., author of the study and Academy member. “Cost of medications, multiple medications, confusing instructions all contribute to a patient’s non-compliance to their therapy.”
Dr. Robin refers to a 2003 Harris poll that illustrates this emerging health concern:
• One-third of patients surveyed took their medications less often than directed
• One-quarter delayed refilling prescriptions
• One-fifth failed to fill prescriptions
• One-fifth stopped taking a medication sooner than prescribed
The World Health Organization (WHO) estimates that worldwide, fifty percent of patients take medications improperly, at a global cost of more than $100 billion in resulting hospital admissions and lost productivity.
Dr. Robin’s study compares medication refill rates for two groups of glaucoma patients. The first group takes a single medication for one year without needing a second medication to control intraocular pressure. The second group takes the same single glaucoma medication for one year, but then a second glaucoma medication is added for an additional year. As soon as a second medication is added, approximately one-half of the second group delayed refilling prescriptions of the first medication by 5 days or more, and 22 percent waited an additional 15 days or more to pick up their pills.
“Non-compliance is a bigger problem then we imagined, and glaucoma therapy is only the tip of the iceberg,” added Dr. Robin. “It becomes a life-and-death situation for doctors to educate and motivate their patients on their therapy and with glaucoma; this may lead to visual disability and blindness.”
Dr. Robin’s study suggests that eye diseases including glaucoma are one of the five conditions at the bottom of the medical condition adherence list. The four other ailments include renal and pulmonary diseases, diabetes, and sleep disorders.
Dr. Robin is an associate professor at both the Johns Hopkins University Schools of Medicine and Public Health.
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.
As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...
Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.
Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...
For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.
While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...
An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.
The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...
A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.
Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...